Panacea Biotec, Russian Direct Investment Fund launch production of Russian Sputnik V vaccine

24 May 2021 Evaluate

Panacea Biotec and The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) have launched production of the Russian Sputnik V vaccine against coronavirus. The first batch produced at Panacea Biotec’s facilities at Baddi will be shipped to the Gamaleya Center for quality control. Full-scale production of the vaccine is due to start this summer, Company’s facilities comply with GMP standards and are prequalified by WHO.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

474.35 22.55 (4.99%)
15-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1705.15
Dr. Reddys Lab 1155.80
Cipla 1481.40
Lupin 2012.05
Zydus Lifesciences 884.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...